Related by context. Frequent words. (Click for all words.) 64 PREZISTA r 62 peginterferon alfa 2b 61 analgesic efficacy 60 Lantus ® 60 #mg/day [001] 60 eszopiclone 60 #mg dose [003] 60 efficacy tolerability 60 fluticasone propionate 60 mg QD 59 plus dexamethasone 59 plus methotrexate 59 tipranavir 59 ARIMIDEX 58 Perforomist TM Inhalation Solution 58 ziprasidone 58 active comparator 58 tiotropium 58 #mg dose [001] 58 long acting beta2 58 irbesartan 58 JANUVIA 58 febuxostat 58 plus ribavirin 58 4mg 58 ketorolac 57 SEROQUEL XR 57 esomeprazole 57 custirsen 57 mg BID 57 severe renal impairment 57 achieved statistical significance 57 RHUCIN 57 peg IFN 57 Secondary endpoints include 57 lopinavir ritonavir 56 PREZISTA 56 mcg dose 56 PEG Intron 56 μg kg 56 #mg/kg [002] 56 Lantus R 56 vomiting CINV 55 PEG INTRON 55 guanfacine 55 vasomotor symptoms 55 Tolerability 55 pharmacodynamic effects 55 glatiramer acetate 55 Copegus 55 PegIntron 55 Diovan HCT 55 oxybutynin 55 ONGLYZA 55 administered subcutaneously 55 dacarbazine 55 renal toxicity 54 budesonide 54 pharmacokinetic profiles 54 glargine 54 dosing interval 54 cardiac toxicity 54 SINGULAIR 54 chlorambucil 54 HCTZ 54 lacosamide 54 levetiracetam 54 mucosal healing 54 exenatide 53 basal insulin 53 Lamictal XR 53 serum phosphorus 53 COPEGUS 53 Secondary endpoints included 53 Secondary endpoints 53 mcg kg 53 subcutaneous injections 53 sulphonylurea 53 HbA1C 53 venous thromboembolic events 53 neuroprotective properties 53 formoterol 53 ramipril 53 Focalin XR 53 pramipexole 53 glimepiride 53 salmeterol 53 unfractionated heparin 53 aliskiren 52 sipuleucel T 52 efficacy 52 Eloxatin R 52 Topiramate 52 sustained virologic response 52 pharmacokinetic profile 52 transcriptase inhibitor NNRTI 52 Cmax 52 pravastatin 52 bronchodilator 52 adecatumumab 52 inactive placebo